Venus Pharma GmbH is involved in the pharmaceutical industry, offering a diverse range of pharmaceutical products to cater to various therapeutic areas and market segments, known for their quality and timely deliveries.

Venus Pharma GmbH

biosyn Arzneimittel GmbH is involved in the pharmaceutical and biotech sectors, specializing in trace elements, particularly high-dose selenium injections, and operates unique GMP-active ingredient manufacturing plants.

biosyn Arzneimittel GmbH

Venus Pharma GmbH | 179 followers on LinkedIn. European center for pharmaceutical products of Venus Remedies Limited | Venus Pharma GmbH is a European pharmaceutical company located in Germany, closely affiliated with Venus Remedies Limited (VRL) yet maintaining its autonomy. Serving as an extended arm of VRL, it proudly represents the footprint of VRL in the European pharmaceutical landscape.  

While primarily engaged in the packaging and warehousing of pharmaceutical products manufactured by Venus Remedies, GmbH&#39;s services are not exclusive to Venus.

International Sales and Business Development I Formulations I APIs I Licensing I Generics I CMO/CDMO I High Potent I Small Molecules I…

Harmit Singh

M.Sc. Arzneimittelwissenschaften | Stellvertretende Leitung der Herstellung und Logistik

Caroline Michalski

𝗘𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝗔𝗜-𝗗𝗿𝗶𝘃𝗲𝗻 𝗩𝗶𝘀𝘂𝗮𝗹 𝗜𝗻𝘀𝗽𝗲𝗰𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗕𝗿𝗲𝘃𝗲𝘁𝘁𝗶 𝗖𝗘𝗔 𝗶𝗻 𝗩𝗶𝗰𝗲𝗻𝘇𝗮 After wrapping up our experience at CPHI Milan, Aditi and I travelled to Vicenza to visit Brevetti-CEA Spa , a company specializing in AI-driven visual inspection machines. It was an inspiring visit that offered a fresh perspective on how AI could elevate visual inspection systems for the pharmaceutical industry by potentially enhancing quality control with unmatched precision, consistency and efficiency, thereby cutting costs and minimizing errors. In the current landscape, AI-driven visual inspection seems to be increasingly important as companies explore ways to detect defects, inconsistencies and anomalies in packaging, labelling and the products themselves. These AI solutions may offer opportunities for greater speed, accuracy and reliability, indicating a notable shift towards automation. As significant investments are being made in AI technologies, the advancements in algorithms might contribute to an evolving automated and data-driven landscape, aligned with the principles of Industry 4.0. What truly stood out at Brevetti was not just its impressive technology, but also its collaborative spirit and openness to innovation. From the shop floor mechanic assembling the machine with all the expertise at his command to the AI researchers sharing their vision for the future, it was clear that their passion for innovation resonated with our own teams at Venus Remedies Limited Remedies, highlighting our mutual commitment to developing the pharmaceutical industry on advanced lines. We are constantly exploring ways to integrate advanced technologies to shape the future of our quality control systems at Venus Remedies. This visit provided valuable insights into how AI-driven hardware and software integration could potentially enhance our processes and drive innovation in our operations. While we’re still considering if this machine can be a future addition to our lineup at Venus Remedies, the potential it brings in terms of hardware and software integration is undeniable. This exploration underscores our commitment to staying attuned to technological advancements that may shape the future of visual inspection. The future of visual inspection appears to be rapidly evolving, and we’re excited about the possibilities it opens up for us, especially as we continue to grow and learn from leading-edge advancements in our industry. #VenusPharma #BrevettiCEA #VisualInspection #AIinPharma #PharmaInnovation #Vicenza #CPHIMilan #PharmaTech #FutureOfPharma #QualityControl

Akshansh C.

𝗘𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝗘𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗧𝗿𝗲𝗻𝗱𝘀 𝗮𝗻𝗱 𝗙𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀: 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗖𝗣𝗵𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟰 CPHI Milan 2024 was a hub of innovation, and I was part of several discussions and sessions that shed light on the future trends shaping the pharmaceutical industry. Here are the most impactful insights: Manufacturing 5.0, The Next Evolution: I attended an eye-opening session on Manufacturing 5.0, where discussions covered AI, cybersecurity and sustainable pharmaceutical packaging. As Venus Remedies Limited advances through Industry 4.0, these insights will guide us in preparing for the next wave of technological advancements. Hikma’s Branding Simplicity: Hikma Pharmaceuticals ' approach to clear, concise branding in their stall design was a standout. The simplicity in conveying the nuances of their core business segments—Generics, Branded, and Injectables—served as a reminder of the power of clarity in communication. This is a strategy I am keen to integrate into our future exhibitions. Sustainability Focus with SGD Pharma: SGD Pharma ’s commitment to reducing Scope 1 and 2 emissions by 35% by 2030 and 65% by 2040 was inspiring. It is evident that sustainability is becoming a defining priority for the industry, and Venus Remedies remains committed to aligning its strategies with such industry-specific goals. These discussions and sessions emphasize the evolving priorities and future direction of the pharmaceutical sector. At Venus Remedies, we are dedicated to adopting and leading these changes to remain at the forefront of the industry. #FutureOfPharma #CPHIMilan #IndustryTrends #VenusRemedies #Pharma #InnovationInPharma #SustainabilityInPharma

𝗕𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗦𝘁𝗿𝗼𝗻𝗴 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀 𝗮𝗻𝗱 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝘁 𝗖𝗣𝗵𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟰 At CPHI Milan 2024, I strengthened key industry relationships and explored new collaborations that align with Venus Remedies Limited ’s vision of growth and innovation. Here are the highlights: Startup Innovation with Axom: I also connected with Axom , a French startup specializing in visual inspection systems. Despite being new to the market, Axom shows promise and innovation, differentiating itself from established players. This interaction helps us understand the broader landscape of visual inspection technologies as we continue our research and development efforts. Fujifilm’s Expansion into Bioprocessing: A fascinating highlight was witnessing Fujifilm transition from its core expertise in imaging technology to bioprocessing solutions for quality control. This expansion by FUJIFILM Wako Chemicals Europe GmbH is inspiring, showcasing how leveraging core strengths can open new avenues in the pharmaceutical industry—a model we aim to emulate at Venus Remedies. Partnership Strengthening with Umicore: I met Umicore ’s sales head, a global leader in precious metals supply. A key player in its domain, Umicore consistently meets our requirements, demonstrating its professionalism and commitment. This ongoing partnership ensures that our supply chain remains robust and reliable. Such partnerships and interactions are vital as we scale up Venus Remedies for continued growth and excellence through strategic collaborations. #GlobalPartnerships #TrustedPartners #StartupInnovation #VenusRemedies #Pharma #CPHIMilan #PharmaExcellence

𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗮𝗻𝗱 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲: 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗖𝗣𝗵𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟰 Pharmaceutical manufacturing is rapidly evolving, and CPHI Milan 2024 provided deep insights into compliance and technological advancements. I engaged with several industry leaders to understand these changes and their implications for Venus Remedies Limited Remedies: West Pharma’s Contamination Control Strategies: In a session by West Pharmaceutical Services , I gained insights into their approach to contamination control, aligned with EU Annex 1 requirements. Their comprehensive documentation strategies ensure full support to vendors, reinforcing the importance of similar documentation processes at Venus Remedies for ensuring compliance. AM Instruments’ Clean Room Compliance Technologies: During an interaction with AM Instruments , I explored their Tyvek Covers, which ensure clean room compliance by preventing fibre generation during autoclaving. They also demonstrated their autoclave indicator, which adds an extra layer of assurance in the sterilization process. Iven Pharma Tech’s Approach to RABS: I engaged with Shanghai IVEN Pharmatech Engineering Co., Ltd Pharmatech Engineering Co to discuss the future of Restricted Access Barrier Systems (RABS). They clarified that closed RABS aren’t mandatory for EU GMP compliance, which in turn offers us flexibility as we design future facilities. This insight is invaluable as Venus Remedies plans to improve its manufacturing systems while maintaining compliance. These discussions reflect our commitment to maintaining the highest standards of sterility, compliance and operational excellence as we continue to innovate and expand our manufacturing capabilities. #PharmaceuticalExcellence #ManufacturingInnovation #ComplianceInPharma #CPHIMilan #VenusRemedies #Pharma #PharmaTech

𝗘𝗺𝗯𝗿𝗮𝗰𝗶𝗻𝗴 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗡𝗲𝘄 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗛𝗼𝗿𝗶𝘇𝗼𝗻𝘀: 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗖𝗣𝗵𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟰 The future of digital transformation in the pharmaceutical industry was a central theme at CPHI Milan 2024. I engaged with several pioneering technology providers to explore how Venus Remedies Limited can leverage these advancements. Here are the highlights: AIZON’s AI-Driven Batch Record Digitization: In my meeting with Aizon , I explored their AI-powered system for digitizing Master Batch Records (MBR). AIZON’s web-based application and AI-driven data migration promise seamless integration and streamlined data entry, ensuring regulatory compliance and greater efficiency. Engagement with Scilife on QMS Software Solutions: Scilife introduced their Quality Management System (QMS) software, which integrates document management, APA tracking and training into a single platform. We’re evaluating a demo to determine its compatibility with our current systems like ClickUp and its potential to enhance our QA/QC processes. Discussion with Vimachem on Manufacturing Digitization: Vimachem - IIoT Pharma 4.0 AI Platform , a company specializing in digitizing physical records and hardware integration, presented exciting prospects for Venus Remedies. Our conversation highlighted the potential to automate data collection in upcoming Venus Remedies facilities—a promising prospect as we expand our manufacturing capabilities. These engagements are crucial as Venus Remedies moves forward with its digital transformation initiatives and ensures that its operations are more efficient, compliant and technologically advanced. #DigitalTransformation #PharmaTech #AIInPharma #VenusRemedies #Pharma #CPHIMilan #InnovationInPharma - Cristian Marfà de la Loma Michael Galán von S. Laura Gilbert Alex Vidras

𝗗𝗿𝗶𝘃𝗶𝗻𝗴 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗣𝗮𝗰𝗸𝗮𝗴𝗶𝗻𝗴: 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗖𝗣𝗵𝗜 𝗠𝗶𝗹𝗮𝗻 𝟮𝟬𝟮𝟰 At CPHI Milan 2024, sustainability was at the forefront of discussions. I had the opportunity to explore and engage with various companies focused on eco-friendly innovations in packaging, something which aligns with Venus Remedies’ commitment to reducing the environmental impact of our operations. Here are the key highlights: Interaction with SCHOTT Pharma : SCHOTT showcased their innovative approach to circular packaging using virgin glass materials designed to return safely to the environment. This technology, focused on eliminating plastics, ensures that all components of the packaging maintain material uniformity. It was encouraging to find SCHOTT, one of our long-time partners, leading the way with such sustainable initiatives. Engagement with Paboco - the paper bottle company I explored a breakthrough innovation—a paper bottle designed to replace traditional plastic bottles. The product by Paboco demonstrated durability and flexibility while being recyclable, presenting a viable eco-friendly solution for our RESET products. Discussion with PluumoPlus : Pluumo+ presented a fascinating feather-based packaging solution as an alternative to styrofoam for logistics and shipping. The material is recyclable and renewable, maintaining temperature stability to match our logistics needs. We’re excited to evaluate this for integration into our supply chain. These discussions reinforced the importance of sustainable innovation in packaging. At Venus Remedies Limited , we remain dedicated to exploring and implementing these solutions to ensure our products are both high quality and environmentally responsible. #SustainabilityInPharma #GreenInnovation #EcoFriendlyPackaging #CPHIMilan #VenusRemedies #Pharma #PharmaInnovation

What an incredible final day at CPhI 2024! Venus Remedies wrapped up this amazing event with innovative showcases and powerful conversations with industry leaders. Thank you to everyone who joined us on this journey! Swipe to catch day 3 highlights! Learn more: https://lnkd.in/g4v5e4kb Know more: https://vrl.bio.link/ #CPHIMilan2024 #CPHIMilanDay3 #HealthcareInnovation #PharmaCollaboration #PharmaceuticalIndustry #GlobalHealthcare #CPHICollaborations #FutureOfHealthcare #InnovateTogether #PharmaPartnerships #MeetTheExperts #VenusRemediesLimited #VenusRemedies

What a thrilling Day 2 at CPhI 2024! The energy was contagious as Venus Remedies connected with industry leaders showcased cutting-edge innovations, and engaged in inspiring discussions. Swipe through to catch all the exciting moments! Ready to collaborate? Book a meeting with us now: https://shorturl.at/hRojH Learn more: https://lnkd.in/g4v5e4kb Know more: https://vrl.bio.link/ #CPHIMilan2024 #CPHIMilanDay2 #HealthcareInnovation #PharmaCollaboration #PharmaceuticalIndustry #GlobalHealthcare #CPHICollaborations #FutureOfHealthcare #InnovateTogether #PharmaPartnerships #MeetTheExperts #VenusRemediesLimited #VenusRemedies

Welcome to Day 2 at CPhI 2024! Venus Remedies is set to unveil more innovative solutions and strengthen global collaborations, as we strive to reshape the future of healthcare. Our journey to push healthcare boundaries continues, and we can’t wait to share what’s next! Book a meeting with us now: https://shorturl.at/hRojH Learn more: https://lnkd.in/g4v5e4kb Know more: https://vrl.bio.link/ #CPHIMilan2024 #CPHIMilanDay2 #HealthcareInnovation #PharmaCollaboration #PharmaceuticalIndustry #GlobalHealthcare #CPHICollaborations #FutureOfHealthcare #InnovateTogether #PharmaPartnerships #MeetTheExperts #VenusRemediesLimited #VenusRemedies

Metric
Company Name	Venus Pharma GmbH	biosyn Arzneimittel GmbH
Symbol
MSH ID	DE:VENUSPHARMAGMBH	DE:BIOSYN
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Pharmaceuticals	Pharmaceuticals
Country	DE	DE
Stage
Employee Count
Website	venuspharmagmbh.de	biosyn.de
LinkedIn	venus-pharma-germany	biosyn-arzneimittel-gmbh
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

VENU

DE:VENUSPHARMAGMBH

Venus Pharma GmbH

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue